VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 102 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,483,000 | -8.3% | 13,049,079 | +29.2% | 2.43% | -13.2% |
| Q1 2022 | $12,521,000 | -24.1% | 10,097,229 | +19.3% | 2.80% | -26.8% |
| Q4 2021 | $16,507,000 | +17.6% | 8,464,999 | +65.2% | 3.82% | +3.3% |
| Q3 2021 | $14,038,000 | +33.8% | 5,123,509 | +53.8% | 3.70% | +1.2% |
| Q2 2021 | $10,494,000 | +32.1% | 3,331,315 | -10.7% | 3.66% | +15.5% |
| Q1 2021 | $7,944,000 | +30.0% | 3,729,694 | +18.4% | 3.16% | -4.7% |
| Q4 2020 | $6,111,000 | – | 3,150,000 | – | 3.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
| VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
| COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
| EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
| HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
| NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
| Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |